Financials · mywealthgrid

Standalone figures · ₹ crore

₹ Cr	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	931	625	965	1,237	1,293	408	1,157	1,193	1,264	529	609	597
COGS	181	111	106	146	156	70	222	184	155	112	124	157
Gross profit	750	515	859	1,091	1,137	337	936	1,009	1,110	417	485	440
	307	276	406	328	346	308	375	469	557	297	393	334
	442	238	453	763	791	29	561	540	553	120	92	106
OPM %	47.5%	38.1%	46.9%	61.7%	61.2%	7.2%	48.5%	45.3%	43.7%	22.8%	15.2%	17.8%
Depreciation	40	40	52	40	42	44	94	54	48	42	46	43
Interest	3	4	5	4	3	3	9	3	12	8	10	10
	25	30	36	40	51	168	62	60	93	55	73	48
Profit before tax	424	224	433	758	797	150	521	543	586	125	110	102
Tax	64	32	83	122	136	25	93	79	85	18	-100	27
Tax %	15.1%	14.1%	19.3%	16.1%	17%	16.9%	17.8%	14.5%	14.5%	14.6%	-90.6%	26.9%
	360	192	349	636	661	125	428	464	501	107	210	75
PAT margin %	38.7%	30.7%	36.2%	51.4%	51.1%	30.6%	37%	38.9%	39.6%	20.2%	34.4%	12.5%
EPS (₹)	20.1	10.7	19.5	35.5	36.9	7	23.9	25.9	28	6	11.7	4.2
Results filing	—	—	—	—	—	—	—	Results filing for Jun 2025	Results filing for Sep 2025	Results filing for Dec 2025	Results filing for Mar 2026	—

vs same quarter last year	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue YoY %	+165%	+51.4%	+23.5%	+18%	+38.9%	-34.8%	+20%	-3.6%

Natco Pharma Limited